121
A Trial to Compare Prophylaxis Therapy to On-demand Therapy With a New Full Length Recombinant FVIII in Patients With Severe Hemophilia A
Condition(s):Hemophilia ALast Updated:November 28, 2016Completed
Factor VIII: 881 Clinical Trials, Page 13 of 89
Hide Studies Not Open or Pending
122
Weight-based Dosing in Hemophilia A
Condition(s):HemophiliaLast Updated:September 25, 2020Terminated
123
Assessment of the Risk of Inhibitor Formation in Previously Treated Patients With Severe Hemophilia A
Condition(s):Hemophilia ALast Updated:December 18, 2014Terminated
124
Efficacy and Safety Study of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Pediatric Patients in Canada With Hemophilia A – A Continuation of Baxter Study 060101
Condition(s):Hemophilia ALast Updated:May 5, 2021Completed
125
A Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of Emicizumab in Participants With Mild or Moderate Hemophilia A Without FVIII Inhibitors
Condition(s):Mild Hereditary Factor VIII Deficiency Disease Without Inhibitor; Moderate Hereditary Factor VIII Deficiency Disease Without Inhibitor; Hemophilia ALast Updated:December 15, 2022Active, not recruiting
126
Trial to Evaluate the Pharmacokinetics and Safety Profile of BAY94-9027 Following Single and Multiple Dose Administration
Condition(s):Hemophilia ALast Updated:September 7, 2018Completed
127
Study Evaluating Pharmacovigilance Of Refacto AF
Condition(s):Hemophilia ALast Updated:July 17, 2018Completed
128
A Study of BAX 888 in Male Adults With Severe Hemophilia A
Condition(s):Hemophilia ALast Updated:November 26, 2021Active, not recruiting
129
Emicizumab PUPs and Nuwiq ITI Study
Condition(s):Hemophilia ALast Updated:February 23, 2022Recruiting
130
Dose-Response Study of Recombinant Factor VIII Manufactured Protein-Free (rAHF-PFM) in Patients With Hemophilia A
Condition(s):Hemophilia ALast Updated:June 10, 2021Completed